{"count": 26, "results": [{"_id": "37509614", "pmid": 37509614, "pmcid": "PMC10377707", "title": "Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients", "journal": "Biomedicines", "authors": ["Rastoder E", "Sivapalan P", "Eklöf J", "Achir Alispahic I", "Jordan AS", "Laursen CB", "Vestbo J", "Jenkins C", "Nielsen R", "Bakke P", "Fernandez-Romero G", "Modin D", "Johansen N", "Davidovski FS", "Biering-Sørensen T", "Carlsen J", "Jensen JUS"], "date": "2023-07-12T00:00:00Z", "doi": "10.3390/biomedicines11071974", "meta_date_publication": "2023 Jul 12", "meta_volume": "11", "meta_issue": "7", "meta_pages": "", "score": 50274.68, "text_hl": "In the group receiving @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, 2803 @SPECIES_9606 @@@patients@@@ had an event of severe exacerbation of @DISEASE_Pulmonary_Disease_Chronic_Obstructive @DISEASE_MESH:D029424 @@@COPD@@@ and 59 @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@died@@@; 2862 (67%) had an event within the 12-month follow-up. ", "citations": {"NLM": "Rastoder E, Sivapalan P, Eklöf J, Achir Alispahic I, Jordan AS, Laursen CB, Vestbo J, Jenkins C, Nielsen R, Bakke P, Fernandez-Romero G, Modin D, Johansen N, Davidovski FS, Biering-Sørensen T, Carlsen J, Jensen JUS. Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients Biomedicines. 2023 Jul 12;11(7):. PMID: 37509614", "BibTeX": "@article{37509614, title={Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients}, author={Rastoder E and Sivapalan P and Eklöf J and Achir Alispahic I and Jordan AS and Laursen CB and Vestbo J and Jenkins C and Nielsen R and Bakke P and Fernandez-Romero G and Modin D and Johansen N and Davidovski FS and Biering-Sørensen T and Carlsen J and Jensen JUS}, journal={Biomedicines}, volume={11}, number={7}}"}}, {"_id": "35337177", "pmid": 35337177, "pmcid": "PMC8952430", "title": "Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension", "journal": "Pharmaceuticals (Basel)", "authors": ["Loas G", "Van de Borne P", "Darquennes G", "Le Corre P"], "date": "2022-03-21T00:00:00Z", "doi": "10.3390/ph15030380", "meta_date_publication": "2022 Mar 21", "meta_volume": "15", "meta_issue": "3", "meta_pages": "", "score": 50272.977, "text_hl": "Univariate and multivariate logistic regressions were used to explore the relationships between mortality and sex, age, comorbidities, smoking, and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ status. Out of the 184 @SPECIES_9606 @@@participants@@@, 132 (71.7%) survived and 52 (28.3%) @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@died@@@. ", "citations": {"NLM": "Loas G, Van de Borne P, Darquennes G, Le Corre P. Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension Pharmaceuticals (Basel). 2022 Mar 21;15(3):. PMID: 35337177", "BibTeX": "@article{35337177, title={Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension}, author={Loas G and Van de Borne P and Darquennes G and Le Corre P}, journal={Pharmaceuticals (Basel)}, volume={15}, number={3}}"}}, {"_id": "41006534", "pmid": 41006534, "title": "In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine.", "journal": "Sci Rep", "authors": ["Dańkowska K", "Nesterowicz M", "Lauko KK", "Trocka D", "Żendzian-Piotrowska M", "Ładny JR", "Zalewska A", "Żebrowska-Gamdzyk M", "Maciejczyk M"], "date": "2025-09-26T00:00:00Z", "doi": "10.1038/s41598-025-18925-8", "meta_date_publication": "2025 Sep 26", "meta_volume": "15", "meta_issue": "1", "meta_pages": "33277", "score": 50257.555, "text_hl": "In addition, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ effectively prevents protein glycation, as evidenced by a reduction in @GENE_APP @GENE_351 @@@amyloid-beta@@@ structure, Amadori products, and @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@advanced glycation end products@@@ (@<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@AGEs@@@). ", "citations": {"NLM": "Dańkowska K, Nesterowicz M, Lauko KK, Trocka D, Żendzian-Piotrowska M, Ładny JR, Zalewska A, Żebrowska-Gamdzyk M, Maciejczyk M. In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine. Sci Rep. 2025 Sep 26;15(1):33277. PMID: 41006534", "BibTeX": "@article{41006534, title={In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine.}, author={Dańkowska K and Nesterowicz M and Lauko KK and Trocka D and Żendzian-Piotrowska M and Ładny JR and Zalewska A and Żebrowska-Gamdzyk M and Maciejczyk M}, journal={Sci Rep}, volume={15}, number={1}, pages={33277}}"}}, {"_id": "32411566", "pmid": 32411566, "pmcid": "PMC7219014", "title": "Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19", "journal": "Cureus", "authors": ["Solaimanzadeh I"], "date": "2020-05-12T00:00:00Z", "doi": "10.7759/cureus.8069", "meta_date_publication": "2020 May 12", "meta_volume": "12", "meta_issue": "5", "meta_pages": "e8069", "score": 50257.18, "text_hl": "@CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@Nifedipine@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ Are Associated With Improved @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@Mortality@@@ and Decreased Risk for Intubation and Mechanical Ventilation in Elderly @SPECIES_9606 @@@Patients@@@ Hospitalized for @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@", "citations": {"NLM": "Solaimanzadeh I. Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19 Cureus. 2020 May 12;12(5):e8069. PMID: 32411566", "BibTeX": "@article{32411566, title={Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19}, author={Solaimanzadeh I}, journal={Cureus}, volume={12}, number={5}, pages={e8069}}"}}, {"_id": "33799977", "pmid": 33799977, "pmcid": "PMC7998809", "title": "Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study", "journal": "Pharmaceuticals (Basel)", "authors": ["Darquennes G", "Le Corre P", "Le Moine O", "Loas G"], "date": "2021-03-07T00:00:00Z", "doi": "10.3390/ph14030226", "meta_date_publication": "2021 Mar 7", "meta_volume": "14", "meta_issue": "3", "meta_pages": "", "score": 50250.996, "text_hl": "Nonsignificant decreasing OR (0.53, 95% CI: 0.27-1.04; p = 0.064) was reported for FIASMA status. For @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ status, multivariable regression revealed increasing OR of in-hospital @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@deaths@@@ associated with older age (OR 1.04, 95% CI: 1.02-1.07; p = 0.0009), higher prevalence of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ (OR 2.78, 95% CI: 1.33-5.79; p = 0.0062) and higher prevalence of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@malignant neoplasm@@@ (OR 2.71, 95% CI: 1.23-5.97; p = 0.013), then secondarily decreasing OR of in-hospital @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@ associated with long-term treatment with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (OR 0.24, 95% CI: 0.09-0.62; p = 0.0031). ", "citations": {"NLM": "Darquennes G, Le Corre P, Le Moine O, Loas G. Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study Pharmaceuticals (Basel). 2021 Mar 7;14(3):. PMID: 33799977", "BibTeX": "@article{33799977, title={Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study}, author={Darquennes G and Le Corre P and Le Moine O and Loas G}, journal={Pharmaceuticals (Basel)}, volume={14}, number={3}}"}}, {"_id": "39947728", "pmid": 39947728, "title": "Delayed onset of non-cardiogenic pulmonary oedema following amlodipine overdose.", "journal": "BMJ Case Rep", "authors": ["Zambetti LD", "Parrish AG"], "date": "2025-02-13T00:00:00Z", "doi": "10.1136/bcr-2024-264112", "meta_date_publication": "2025 Feb 13", "meta_volume": "18", "meta_issue": "2", "meta_pages": "", "score": 50250.32, "text_hl": "...@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, a widely used antihypertensive medication, can cause serious complications in @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@, including @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotension@@@, @DISEASE_Bradycardia @DISEASE_MESH:D001919 @@@bradycardia@@@, @DISEASE_Syncope @DISEASE_MESH:D013575 @@@non-cardiogenic pulmonary oedema@@@ (@DISEASE_Syncope @DISEASE_MESH:D013575 @@@NCPO@@@) and @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@. ", "citations": {"NLM": "Zambetti LD, Parrish AG. Delayed onset of non-cardiogenic pulmonary oedema following amlodipine overdose. BMJ Case Rep. 2025 Feb 13;18(2):. PMID: 39947728", "BibTeX": "@article{39947728, title={Delayed onset of non-cardiogenic pulmonary oedema following amlodipine overdose.}, author={Zambetti LD and Parrish AG}, journal={BMJ Case Rep}, volume={18}, number={2}}"}}, {"_id": "38045912", "pmid": 38045912, "pmcid": "PMC10690815", "title": "Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study", "journal": "Front Cardiovasc Med", "authors": ["Bae S", "Kim WK", "You SC", "Kim M", "Jung IH"], "date": "2023-11-17T00:00:00Z", "doi": "10.3389/fcvm.2023.1305824", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "1305824", "score": 50249.105, "text_hl": "During the 5-year follow-up period, 6,798 @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@deaths@@@ were reported. @SPECIES_9606 @@@Patients@@@ receiving @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ had a significantly lower risk of all-cause @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@ than those not receiving @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (32.0 vs. 56.6 per 100,000 person-years, adjusted HR: 0.64, 95% CI: 0.59-0.70, p < 0.001; Table 2 and Figure 2). ", "citations": {"NLM": "Bae S, Kim WK, You SC, Kim M, Jung IH. Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study Front Cardiovasc Med. 2023;10():1305824. PMID: 38045912", "BibTeX": "@article{38045912, title={Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study}, author={Bae S and Kim WK and You SC and Kim M and Jung IH}, journal={Front Cardiovasc Med}, volume={10}, pages={1305824}}"}}, {"_id": "33229823", "pmid": 33229823, "title": "A Portable Reflective Absorbance Spectrophotometric Smartphone Device for the Rapid and Highly Accurate Determination of Amlodipine in Pharmaceutical Formulation and Human Urine Samples.", "journal": "Anal Sci", "authors": ["Khachornsakkul K", "Dungchai W"], "date": "2021-07-10T00:00:00Z", "doi": "10.2116/analsci.20P349", "meta_date_publication": "2021 Jul 10", "meta_volume": "37", "meta_issue": "7", "meta_pages": "963-969", "score": 50245.844, "text_hl": "The immediate analysis of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in the @SPECIES_9606 @@@human@@@ urine of the @SPECIES_9606 @@@patients@@@ who suffered severe side effects of this drug is very important for the diagnosis, treatment, and reduction of the @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@ rate. ", "citations": {"NLM": "Khachornsakkul K, Dungchai W. A Portable Reflective Absorbance Spectrophotometric Smartphone Device for the Rapid and Highly Accurate Determination of Amlodipine in Pharmaceutical Formulation and Human Urine Samples. Anal Sci. 2021 Jul 10;37(7):963-969. PMID: 33229823", "BibTeX": "@article{33229823, title={A Portable Reflective Absorbance Spectrophotometric Smartphone Device for the Rapid and Highly Accurate Determination of Amlodipine in Pharmaceutical Formulation and Human Urine Samples.}, author={Khachornsakkul K and Dungchai W}, journal={Anal Sci}, volume={37}, number={7}, pages={963-969}}"}}, {"_id": "31782677", "pmid": 31782677, "title": "Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China.", "journal": "J Med Econ", "authors": ["Ren M", "Xuan D", "Lu Y", "Fu Y", "Xuan J"], "date": "2020-04-01T00:00:00Z", "doi": "10.1080/13696998.2019.1699799", "meta_date_publication": "2020 Apr", "meta_volume": "23", "meta_issue": "4", "meta_pages": "394-400", "score": 50245.164, "text_hl": "Probability sensitivity analyses (PSA) and one-way sensitivity analyses were conducted for the main parameters to test the robustness of the model.Results: Compared to @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@olmesartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ free combination, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ fixed-dose combination, treatment with @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@olmesartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ fixed-dose combination led to fewer CVD events and @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@deaths@@@; resulted in an incremental cost of $-5,439 ($-791.36), $6,530 ($950.09), and $-1,019 ($-148.26) and gained additional QALYs of 0.052, 0.094, and 0.037 per @SPECIES_9606 @@@patient@@@, respectively. ", "citations": {"NLM": "Ren M, Xuan D, Lu Y, Fu Y, Xuan J. Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China. J Med Econ. 2020 Apr;23(4):394-400. PMID: 31782677", "BibTeX": "@article{31782677, title={Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China.}, author={Ren M and Xuan D and Lu Y and Fu Y and Xuan J}, journal={J Med Econ}, volume={23}, number={4}, pages={394-400}}"}}, {"_id": "33403970", "pmid": 33403970, "title": "Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.", "journal": "S Afr Med J", "authors": ["Jones J", "Swart A", "Tommy E", "Cohen K", "Stewart A", "Voget J", "Blockman M"], "date": "2020-11-27T00:00:00Z", "doi": "10.7196/SAMJ.2020.v110i12.14721", "meta_date_publication": "2020 Nov 27", "meta_volume": "110", "meta_issue": "12", "meta_pages": "1226-1230", "score": 50231.926, "text_hl": "Seven @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@deaths@@@ were reported; 3 of these reports of @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@deaths@@@ had confirmed ADRs, and these ADRs were assessed as contributing to the @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@deaths@@@. ", "citations": {"NLM": "Jones J, Swart A, Tommy E, Cohen K, Stewart A, Voget J, Blockman M. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa. S Afr Med J. 2020 Nov 27;110(12):1226-1230. PMID: 33403970", "BibTeX": "@article{33403970, title={Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.}, author={Jones J and Swart A and Tommy E and Cohen K and Stewart A and Voget J and Blockman M}, journal={S Afr Med J}, volume={110}, number={12}, pages={1226-1230}}"}}]}